Physician profile
Patrick J Probst
NPI 1619331220
$13,558.74
in general payments reported to CMS, 2019-2025
41 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $578 · 2023: $1,262 · 2024: $943 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,315 · Food and Beverage: $5,299 · Travel and Lodging: $1,003 · Education: $16.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,315.00 |
| Food and Beverage | $5,298.65 |
| Travel and Lodging | $1,003.32 |
| Education | $16.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $4,200.00 | 2025 | |
| Janssen Global Services, LLC | $3,241.96 | 2025 | |
| Procept Biorobotics Corporation | $1,811.84 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Urogen Pharma, INC. | $1,066.16 | 2022-2025 | |
| Intuitive Surgical, INC. | $279.33 | 2022-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $276.98 | 2021-2025 | Spaceoar Vue System - 10ml |
| Histosonics, INC. | $262.53 | 2024-2025 | |
| Teleflex LLC | $255.10 | 2022-2025 | Urolift |
| Sumitomo Pharma America, INC. | $208.25 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $204.45 | 2025 | Signia, Ligasure |
| C. R. Bard, INC. & Subsidiaries | $168.11 | 2023 | Bard Urinary Drainage Bag |
| Koelis INC. | $164.11 | 2022 | |
| Janssen Biotech, INC. | $163.62 | 2024-2025 | Erleada, Akeega |
| Abbvie INC. | $150.65 | 2022-2025 | |
| Antares Pharma, INC. | $116.66 | 2023-2025 | Xyosted, Tlando, Nocdurna |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $105.48 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Janssen Scientific Affairs, LLC | $79.74 | 2024 | Erleada |
| Blue Earth Diagnostics | $74.17 | 2023-2025 | Posluma |
| Olympus America INC. | $70.41 | 2023-2025 | Itind System, Soltive |
| Baxter Healthcare | $62.50 | 2024 | Perclot |
| Tela Bio, INC. | $55.56 | 2022 | |
| Axogen | $55.38 | 2025 | Axoguard Ha+ Nerve Protector |
| Becton, Dickinson and Company | $42.32 | 2023 | Bard Urinary Drainage Bag |
| Coloplast Corp | $40.97 | 2023 | Porges Coloplast |
| Calyxo, INC. | $39.96 | 2025 | Cvac Aspiration System |
| Immunitybio, INC. | $35.33 | 2025 | |
| 180 Medical, INC. | $34.27 | 2023 | Speedicath |
| Halozyme INC | $32.93 | 2023 | |
| Telix Pharmaceuticals | $24.61 | 2022 | |
| Myovant Sciences INC. | $24.14 | 2022 | |
| Endo USA, INC. | $23.58 | 2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $23.02 | 2023 | Pylarify |
| Cycle Pharmaceuticals INC | $21.08 | 2025 | Venxxiva |
| Endo Pharmaceuticals INC. | $20.45 | 2023 | Xiaflex |
| Astellas Pharma US INC | $19.94 | 2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $19.20 | 2025 | Lynparza |
| Azurity Pharmaceuticals, INC. | $18.67 | 2025 | Azmiro |
| Biotissue Holdings INC. | $18.44 | 2023 | |
| Ucb, INC. | $16.87 | 2025 | Bimzelx |
| Laborie Medical Technologies Corp. | $15.76 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Probst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.